Risk of invasive pneumococcal disease in patients with asplenia/hyposplenism: A nationwide population-based study in Korea, 2009–2018

Risk of invasive pneumococcal disease in patients with asplenia/hyposplenism: A nationwide population-based study in Korea, 2009–2018

Objectives: We aimed to determine the incidence and relative risk (RR) of invasive pneumococcal disease (IPD) in patients with asplenia/hyposplenism, using a nationwide population-based database. Methods: From 2009 to 2018, all claimed cases of newly diagnosed asplenia/hyposplenism in the National H...

Full description

Bibliographic Details
Main Authors:	Ji-Man Kang, Eun Hwa Kim, Kyong Ihn, Inkyung Jung, Minkyung Han, Jong Gyun Ahn
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	International Journal of Infectious Diseases
Subjects:	Asplenia Invasive pneumococcal disease Relative risk Splenectomy Population-based study
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220305567

Similar Items

Sporadic isolated congenital asplenia with fulminant pneumococcal meningitis: a case report and updated literature review
by: Shigeo Iijima
Published: (2017-12-01)

Corrigendum to “Risk of invasive pneumococcal disease in patients with asplenia/hyposplenism: A nationwide population-based study in Korea, 2009–2018” [Int. J. Infect. Dis. 98 September (2020) 486-493]
by: Ji-Man Kang, et al.
Published: (2020-10-01)

Pneumococcal purpura fulminans in asplenic or hyposplenic patients: a French multicenter exposed-unexposed retrospective cohort study
by: Damien Contou, et al.
Published: (2020-02-01)

Prevention of post-splenectomy sepsis in patients with asplenia - a study protocol of a controlled trial
by: Marianne Bayrhuber, et al.
Published: (2020-01-01)

Pneumococcal serotype-specific IgG and opsonophagocytic activity in young Japanese patients with asplenia
by: Kenichi Takeshita, et al.
Published: (2021-10-01)

<i>Streptococcus pneumoniae</i> Infection in Patients with Asplenia: A Spanish Perspective over a 25-Year Period
by: Enrique Gea-Izquierdo, et al.
Published: (2024-01-01)

The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism
by: Sari Peretz, et al.
Published: (2022-08-01)

Impact of pretransplant asplenia vaccination on anti‐A/B antibody titers in prospective ABO incompatible kidney transplant recipients
by: Elisa Bongetti, et al.
Published: (2023-03-01)

Prenatal diagnosis of asplenia syndrome with sliding hiatus hernia in a fetus
by: Balaganesh Karmegaraj, et al.
Published: (2020-01-01)

Germline 3p22.1 microdeletion encompassing RPSA gene is an ultra-rare cause of isolated asplenia
by: Aleksandra Oszer, et al.
Published: (2021-11-01)

Heterotaxy syndrome with complex congenital heart disease, facial palsy, and asplenia: A rare newborn finding
by: Sanjeev Kharel, et al.
Published: (2021-08-01)

Impact of a spleen registry on optimal post-splenectomy vaccination and care
by: Sarah Luu, et al.
Published: (2018-12-01)

The inverse correlation between serum levels of anti-pneumococcal and ferritin after pneumococcal vaccination in splenectomised beta thalassemia major
by: Karamatollah Rahmanian, et al.
Published: (2022-06-01)

Congenital Asplenia Interrupts Immune Homeostasis and Leads to Excessive Systemic Inflammation in Zebrafish
by: Lang Xie, et al.
Published: (2021-06-01)

Recommended vaccinations for asplenic and hyposplenic adult patients
by: Paolo Bonanni, et al.
Published: (2017-02-01)

Case report: Single-cell mapping of peripheral blood mononuclear cells from a patient with both Crohn’s disease and isolated congenital asplenia
by: Dan Pu, et al.
Published: (2022-08-01)

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea
by: Eun Hwa Choi, et al.
Published: (2011-04-01)

Pneumococcus beyond an Austrian syndrome – A case report
by: Gonçalo Guerreiro, et al.
Published: (2022-01-01)

Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study
by: Mohammad Sadegh Rezai, et al.
Published: (2017-01-01)

Spleen angiosarcoma: a world review
by: Lee, Brian Juin Hsien, et al.
Published: (2022)

Endocarditis por Bordetella holmesii en un paciente asplénico
by: Rolando N Soloaga, et al.

Función esplénica en la anemia drepanocítica Splenic function in sickle cell anemia
by: Ileana Nordet Carrera, et al.
Published: (2004-12-01)

Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009–2011
by: Roger R. Fan, et al.
Published: (2016-11-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

Influência do baço, da asplenia e do implante esplênico autógeno no metabolismo lipídico de camundongos
by: Alice Belleigoli Rezende, et al.

Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009–2014
by: Michal Chowers, et al.
Published: (2017-01-01)

Sickle cell disease and malaria: decreased exposure and asplenia can modulate the risk from Plasmodium falciparum
by: Richard O. Mwaiswelo, et al.
Published: (2020-04-01)

Intrafamilial Transmission of Pneumococcal Acute Spontaneous Peritonitis
by: Ioanna Papadatou, et al.
Published: (2023-05-01)

Anti-infectious prophylaxis after splenectomy: current practice in an eastern region of Switzerland
by: C Moll, et al.
Published: (2005-05-01)

64 MDCT 3D Assessment of Complex Congenital Heart and Bilateral Tracheal Bronchi: A Case Report
by: Supika Kritsaneepaiboon, et al.
Published: (2015-04-01)

A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
by: Marta Moreira, et al.
Published: (2017-06-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
by: Angel Vila-Córcoles, et al.
Published: (2023-04-01)

Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
by: Cornelis H. van Werkhoven
Published: (2017-05-01)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
by: Hye-Young Kim, et al.
Published: (2021-03-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
by: Salini Mohanty, et al.
Published: (2023-01-01)

Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018
by: Tianyan Hu, et al.
Published: (2022-09-01)